Peyronie's Disease News and Research

RSS
Of all penile diseases, Peyronie’s disease represents one with often devastating physical and psychological consequences on affected individuals. Also known as induratio penis plastica, this is an incurable, fibrotic (scarring) disease that results in penile curvature, erectile dysfunction and subsequent coital failure.
Increased risk of cancer among men with a curved penis

Increased risk of cancer among men with a curved penis

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

Endo Pharmaceuticals supports efforts to bring first ever treatment guidelines for Peyronie's Disease

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

Auxilium Pharmaceuticals reports total revenues of $109.6 million for Q3 2014

Auxilium Pharmaceuticals reports total revenues of $109.6 million for Q3 2014

ED more prevalent than previously thought

ED more prevalent than previously thought

BioSpecifics Technologies total revenue for second quarter decreases by 19%

BioSpecifics Technologies total revenue for second quarter decreases by 19%

Auxilium Pharmaceuticals' total revenues decrease 17% to $83 million in Q2 2014

Auxilium Pharmaceuticals' total revenues decrease 17% to $83 million in Q2 2014

Auxilium Pharmaceuticals presents new XIAFLEX clinical trial data at AUA Meeting

Auxilium Pharmaceuticals presents new XIAFLEX clinical trial data at AUA Meeting

Prostate cancer breakthroughs offer new hope for men

Prostate cancer breakthroughs offer new hope for men

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Auxilium Pharmaceuticals’ net revenues increase $125.9M to 56%

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium seeks FDA approval for XIAFLEX sBLA to treat multiple Dupuytren's contracture cords concurrently

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

Auxilium doses first patient in CCH Phase 2b study for treatment frozen shoulder syndrome

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

FDA extends PDUFA goal date for Auxilium Pharmaceuticals' sBLA for XIAFLEX

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Study suggests erectile dysfunction in young men may be more prevalent than previously thought

Study suggests erectile dysfunction in young men may be more prevalent than previously thought

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

The Journal of Urology publishes results from BioSpecifics XIAFLEX trials on Peyronie's disease

Additional data from Auxilium XIAFLEX phase III studies on Peyronie's disease

Additional data from Auxilium XIAFLEX phase III studies on Peyronie's disease